Local Healthcare Providers Lead Nation in Addressing Diabetic Eye Disease Crisis

Share Article

November is Diabetes Awareness Month. Alabama has the second highest population of adults in the nation living with diabetes. 40-60 percent of diabetics in Mobile fail to receive an annual retina screening, leading to hundreds with potential vision loss. Intelligent Retinal Imaging System's new FDA-approved screening technology expands access in Mobile to screenings for diabetics.

Local healthcare providers Internal Medicine Center located at SpringHill Hospital and Healthcare Services Physicians at Mobile Diagnostic Center have partnered with Retina Specialty Institute to offer Intelligent Retinal Imaging System(IRIS) screenings to diabetic patients during their regularly scheduled visits.

Retina screenings are critical to detect and prevent Diabetic Retinopathy, the leading cause of preventable blindness in the United States. It is often too late to effectively reverse the condition once patients experience symptoms.

“Severe vision loss can usually be prevented with early diagnosis and treatment,” says Dr. Sunil Gupta of Retina Specialty Institute, the creator of IRIS. “We have the ability to effectively treat and prevent Diabetic Retinopathy, however thousands of diabetics locally go unscreened because of logistical barriers to access. IRIS removes those barriers and provides a quick and convenient screening with rapid results at the point of primary care.”

IRIS incorporates a new FDA approved screening technology proven to be 97% accurate at automatically detecting signs of Diabetic Retinopathy. Patients and their physicians receive preliminary screening results in less than 15 minutes through cloud technology, and a final report by a skilled retina specialist within 24 hours.

Mobile is the first city in the nation to offer IRIS screenings at multiple healthcare centers. A significant number of patients have received screenings in Mobile, Ala. and Pensacola, Fla. since the introduction of IRIS in October, leading to early detection for several patients who would have gone untreated without a screening.


About Intelligent Retinal Imaging System (IRIS):
IRIS makes screenings for Diabetic Retinopathy more efficient, accessible and affordable, delivering higher quality patient care and greater systemic efficiency. IRIS is actively building partnerships with retina groups, healthcare systems and insurers across the country to save sight for millions of diabetics through early detection. More information can be found at RetinalScreenings.com.

Sunil Gupta, M.D., founder of Retina Specialty Institute, is recognized as one of the leading retina surgeons in the United States. His life’s work focuses on advancing treatment of the retina and creating technologies that address critical needs in the healthcare system.

Retina Specialty Institute is a nationally recognized leader in prevention, research and treatment of retina-related diseases. The medical group serves patients in Mississippi, Alabama, Louisiana, and Florida.

Share article on social media or email:

View article via:

Pdf Print